Leifer BS, Doyle SK, Richters A, Evans HL, Koehler AN. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives. Methods Enzymol. 2018;610:191-218. doi:10.1016/bs.mie.2018.09.019.

Singh G, Dahlin JL, Walters MA. Risk Management in Early Discovery Medicinal Chemistry. Methods Enzymol. 2018;610:1-25. doi:10.1016/bs.mie.2018.09.012.

Jordi J, Guggiana-Nilo D, Bolton AD, et al. High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy. Sci Adv. 2018;4(10):eaav1966. doi:10.1126/sciadv.aav1966.

Bagheri N, Carpenter AE, Lundberg E, Plant AL, Horwitz R. The new era of quantitative cell imaging-challenges and opportunities. Mol Cell. 2022;82(2):241-247. doi:10.1016/j.molcel.2021.12.024.

Mahajan A, Taliun D, Thurner M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505-1513. doi:10.1038/s41588-018-0241-6.

Marian CA, Stoszko M, Wang L, et al. Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal. Cell Chem Biol. 2018;25(12):1443-1455.e14. doi:10.1016/j.chembiol.2018.08.004.

Shaw SY, Tran K, Castoreno AB, et al. Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules. ACS Chem Biol. 2013;8(12):2724-33. doi:10.1021/cb400352d.

Li G, Martínez-Bonet M, Wu D, et al. High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. Nat Genet. 2018;50(8):1180-1188. doi:10.1038/s41588-018-0159-z.

Kulesa A, Kehe J, Hurtado JE, Tawde P, Blainey PC. Combinatorial drug discovery in nanoliter droplets. Proc Natl Acad Sci U S A. 2018;115(26):6685-6690. doi:10.1073/pnas.1802233115.

Abazeed ME, Adams DJ, Hurov KE, et al. Integrative radiogenomic profiling of squamous cell lung cancer. Cancer Res. 2013;73(20):6289-98. doi:10.1158/0008-5472.CAN-13-1616.